Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report

Journal of Medical Case Reports

Volumn 5, Issue , 2011, Pages

  Otto, Sven ^a   Sotlar, Karl ^a   Ehrenfeld, Michael ^a   Pautke, Christoph ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CLINDAMYCIN; ZOLEDRONIC ACID;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; JAW OSTEONECROSIS; MOUTH EXAMINATION; ORAL SURGERY; POSTMENOPAUSE OSTEOPOROSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TOOTH EXTRACTION;

EID: 80053173149     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-5-477     Document Type: Article

References (10)

1. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. Marx RE, J Oral Maxillofac Surg 2003 61 9 1115 1117 10.1016/S0278-2391(03)00720-1 12966493 (Pubitemid 37064711)
2. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons, J Oral Maxillofac Surg 2007 65 3 369 376 17307580
3. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. Walter C, Al-Nawas B, Grotz KA, Thomas C, Thuroff JW, Zinser V, Gamm H, Beck J, Wagner W, Eur Urol 2008 54 5 1066 1072 10.1016/j.eururo.2008.06. 070 18602738
4. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS, J Oral Maxillofac Surg 2010 68 2 243 253 10.1016/j.joms.2009.03.050 19772941
5. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence - a multi-centre study. Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A, Mücke T, Mast G, Köhnke R, Volkmer E, Haasters F, Lieger O, Iizuka T, Porter S, Campisi G, Colella G, Ploder O, Neff A, Wiltfang J, Ehrenfeld M, Kreusch T, Wolff KD, Stürzenbaum SR, Schieker M, Pautke C, J Craniomaxillofac Surg 2011 39 4 272 277 10.1016/j.jcms.2010.05. 009 20580566
6. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, N Engl J Med 2007 356 18 1809 1822 10.1056/NEJMoa067312 17476007 (Pubitemid 46698462)
7. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J, Kreutzer K, Hohlweg-Majert B, Wolff KD, Hafner S, Mast G, Ehrenfeld M, Sturzenbaum SR, Kolk A, J Oral Maxillofac Surg 2011 69 1 84 91 10.1016/j.joms.2010.07.014 20971542
8. Osteoporosis. Sambrook P, Cooper C, Lancet 2006 67 9527 2010 2018 (Pubitemid 43867702)
9. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B, J Oral Maxillofac Surg 2009 67 5 Suppl 2 12 19835745
10. Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle? Otto S, Hafner S, Mast G, Tischer T, Volkmer E, Schieker M, Sturzenbaum SR, von Tresckow E, Kolk A, Ehrenfeld M, Pautke C, J Oral Maxillofac Surg 2010 68 5 1158 1161 10.1016/j.joms.2009.07.079 20138420